Advances in Closed-Loop Insulin Delivery Systems in Patients with Type 1 Diabetes

[1] Eisenbarth GS(1986)Type 1 diabetes mellitus. A chronic autoimmune disease N Engl J Med 314 1360-1368

[2] Nathan DM(1993)The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 977-986

[3] Genuth S(1997)Hypoglycemia in the diabetes control and complications trial Diabetes 46 271-286

[4] Lachin J(2008)The barrier of hypoglycemia in diabetes Diabetes 57 3169-3176

[5] Cleary P(2014)Closed-loop artificial pancreas systems: engineering the algorithms Diabetes Care 37 1191-1197

[6] Crofford O(2014)Closed-loop artificial pancreas systems: physiological input to enhance next-generation devices Diabetes Care 37 1184-1190

[7] Cryer PE(2014)The artificial pancreas: are we there yet? Diabetes Care 37 1182-1183

[8] Doyle FJ(2013)The critical path from pump to pancreas: the impact of FDA regulation on the development of a closed-loop diabetes management system Food Drug Law J 68 53-76

[9] Huyett LM(2016)Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes JAMA 316 1407-1408

[10] Lee JB(2017)Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes Diabetes Technol Ther 19 155-163

[1] Eisenbarth GS(1986)Type 1 diabetes mellitus. A chronic autoimmune disease N Engl J Med 314 1360-1368

[2] Nathan DM(1993)The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 977-986

[3] Genuth S(1997)Hypoglycemia in the diabetes control and complications trial Diabetes 46 271-286

[4] Lachin J(2008)The barrier of hypoglycemia in diabetes Diabetes 57 3169-3176

[5] Cleary P(2014)Closed-loop artificial pancreas systems: engineering the algorithms Diabetes Care 37 1191-1197

[6] Crofford O(2014)Closed-loop artificial pancreas systems: physiological input to enhance next-generation devices Diabetes Care 37 1184-1190

[7] Cryer PE(2014)The artificial pancreas: are we there yet? Diabetes Care 37 1182-1183

[8] Doyle FJ(2013)The critical path from pump to pancreas: the impact of FDA regulation on the development of a closed-loop diabetes management system Food Drug Law J 68 53-76

[9] Huyett LM(2016)Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes JAMA 316 1407-1408

[10] Lee JB(2017)Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes Diabetes Technol Ther 19 155-163